We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 2,415

PBM Contracting Transparency: Pennsylvania Auditor General Releases PBM Report
  • Dinsmore & Shohl LLP
  • USA
  • December 14 2018

On December 11, 2018, Pennsylvania Auditor General Eugene A. Depasquale released a long-awaited report discussing the role of pharmacy benefit


CMS Proposes Changes to Medicare Advantage and Part D Drug Pricing
  • K&L Gates
  • USA
  • December 6 2018

On November 30, 2018, the Centers for Medicare & Medicaid Services (“CMS”) published a proposed rule (“Proposed Rule”) to revise certain existing


Health Headlines - December 3, 2018
  • King & Spalding LLP
  • USA
  • December 3 2018

On November 26, 2018, CMS published a proposed rule (the Proposed Rule) to amend the Medicare


CMS Proposes Revised Prescription Drug Regulations to Lower Drug Prices and Reduce Out of Pocket Expenses
  • Robinson & Cole LLP
  • USA
  • November 27 2018

The Centers for Medicare and Medicaid Services (CMS) announced a Proposed Rule to amend Medicare Advantage (MA) regulations and Prescription Drug


New Podcast: Would CMS’s Drug Price Transparency Requirement Really Lower Prices?
  • Manatt Phelps & Phillips LLP
  • USA
  • November 26 2018

On October 15, the Trump administration published a proposed rule that, if finalized, would require prescription drugmakers to include drug price


116th Congress: House Dems Poised to Investigate Prescription Drug Pricing
  • Venable LLP
  • USA
  • November 15 2018

As Democrats secured the House in the midterm elections last week, many industries and issues became front and center as likely targets of


Cannabis: “Consumer” Protection
  • Langlois Lawyers LLP
  • Canada
  • November 9 2018

Cannabis is now a consumer product in Quebec already captured by a restrictive legislative framework, which includes the Consumer Protection Act1


Cannabis : protection du consommateur
  • Langlois Lawyers LLP
  • Canada
  • November 9 2018

Le cannabis est désormais un produit de consommation au Québec déjà encadré par un large éventail législatif restrictif, lequel comprend la Loi sur la


FDA Regulatory and Compliance Monthly Recap November 2018
  • Loeb & Loeb LLP
  • USA
  • November 8 2018

Medical device enforcement report points to heightened oversight, uptick in foreign inspections The report signals an uptick in device inspections


Medicare further expands payment for and coverage of telehealth and similar services
  • Hogan Lovells
  • USA
  • November 7 2018

Through several recently published rules, the Centers for Medicare & Medicaid Services (CMS) is making it possible for Medicare beneficiaries to have